AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 187 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $331,000 | -79.6% | 9,500 | -76.8% | 0.13% | -59.3% |
| Q3 2015 | $1,625,000 | -59.2% | 40,910 | -29.1% | 0.33% | -54.9% |
| Q2 2015 | $3,987,000 | -8.9% | 57,730 | -27.9% | 0.73% | -7.3% |
| Q1 2015 | $4,376,000 | +16.1% | 80,050 | -9.4% | 0.79% | +75.4% |
| Q4 2014 | $3,768,000 | -47.5% | 88,400 | -60.7% | 0.45% | +3.9% |
| Q3 2014 | $7,181,000 | +139.4% | 225,050 | +55.4% | 0.43% | +224.1% |
| Q2 2014 | $3,000,000 | – | 144,810 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,344,620 | $116,393,000 | 6.64% |
| Consonance Capital Management LP | 1,026,902 | $35,736,000 | 3.92% |
| FALCON POINT CAPITAL, LLC | 801,944 | $27,908,000 | 3.74% |
| Credit Capital Investments LLC | 72,813 | $2,534,000 | 3.24% |
| Crosspoint Capital Strategies, LLC | 99,274 | $3,455,000 | 3.07% |
| Camber Capital Management LP | 611,390 | $21,276,000 | 1.11% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 40,901 | $1,423,000 | 1.04% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 344,103 | $11,974,000 | 0.83% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 572,500 | $19,923,000 | 0.66% |
| AlphaOne Investment Services, LLC | 66,105 | $2,301,000 | 0.64% |